论文信息 - Dihydrexidine, a full dopamine D1 agonist, reduces MPTP-induced parkinsonism in monkeys. - 字舞流文

Dihydrexidine, a full dopamine D1 agonist, reduces MPTP-induced parkinsonism in monkeys.

R. Mailman | R. Roth | JaneR . Taylor | D. E. Redmond | J. Taylor | M. Lawrence | J. Elsworth | D. Redmond | D. Nichols | D. Redmond

[1] R. Mailman,et al. Behavioral effects in the rat of dihydrexidine, a high-potency, full-efficacy D1 dopamine receptor agonist. , 1991, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

[2] M. Lawrence,et al. MPTP lesions and dopaminergic drugs alter eye blink rate in African green monkeys , 1991, Pharmacology Biochemistry and Behavior.

[3] R. Mailman,et al. trans-10,11-dihydroxy-5,6,6a,7,8,12b-hexahydrobenzo[a]phenanthridine: a highly potent selective dopamine D1 full agonist. , 1990, Journal of medicinal chemistry.

[4] R. Mailman,et al. Dihydrexidine, a novel selective high potency full dopamine D-1 receptor agonist. , 1989, European journal of pharmacology.

[5] T. Chase,et al. D-1/D-2 dopamine receptor interactions in the regulation of extrapyramidal motor function: studies in animal models and parkinsonian patients. , 1986, Clinical neuropharmacology.